[HTML][HTML] 2020 Seoul consensus on the diagnosis and management of gastroesophageal reflux disease

HK Jung, CH Tae, KH Song, SJ Kang… - Journal of …, 2021 - ncbi.nlm.nih.gov
Gastroesophageal reflux disease (GERD) is a condition in which gastric contents regurgitate
into the esophagus or beyond, resulting in either troublesome symptoms or complications …

[HTML][HTML] Advantages and disadvantages of long-term proton pump inhibitor use

Y Kinoshita, N Ishimura, S Ishihara - … of neurogastroenterology and …, 2018 - ncbi.nlm.nih.gov
Proton pump inhibitors (PPIs) potently inhibit gastric acid secretion and are widely used for
treatment of acid-related diseases including gastroesophageal reflux disease and …

SAGES guidelines for the surgical treatment of gastroesophageal reflux (GERD)

BJ Slater, RC Dirks, SK McKinley, MT Ansari… - Surgical …, 2021 - Springer
Abstract Background Gastroesophageal Reflux Disease (GERD) is an extremely common
condition with several medical and surgical treatment options. A multidisciplinary expert …

Gastroesophageal reflux disease.

R Kellerman, T Kintanar - Primary care, 2017 - europepmc.org
Gastroesophageal reflux disease (GERD) is a gastrointestinal motility disorder that results
from the reflux of stomach contents into the esophagus or oral cavity resulting in symptoms …

[HTML][HTML] Potent potassium-competitive acid blockers: a new era for the treatment of acid-related diseases

T Oshima, H Miwa - Journal of neurogastroenterology and motility, 2018 - ncbi.nlm.nih.gov
Conventional proton pump inhibitors (PPIs) are used as a first-line therapy to treat acid-
related diseases worldwide. However, they have a number of limitations including slow …

Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive …

Y Xiao, S Zhang, N Dai, G Fei, KL Goh, HJ Chun… - Gut, 2020 - gut.bmj.com
Objective To establish the non-inferior efficacy of vonoprazan versus lansoprazole in the
treatment of Asian patients with erosive oesophagitis (EO). Design In this phase III, double …

Endoscopic cyanoacrylate injection versus balloon‐occluded retrograde transvenous obliteration for prevention of gastric variceal bleeding: a randomized controlled …

X Luo, T Xiang, J Wu, X Wang, Y Zhu, X Xi, Y Yan… - Hepatology, 2021 - journals.lww.com
Conclusions TNIP3 is a regulator of hepatic I/R injury that alleviates cell death and
inflammation by assisting ubiquitination and degradation of LATS2 and the resultant YAP …

Intestinal dysbiosis secondary to proton-pump inhibitor use

Y Naito, K Kashiwagi, T Takagi, A Andoh, R Inoue - Digestion, 2018 - karger.com
Background: Gut dysbiosis associated with the use of proton-pump inhibitors (PPIs) has
been found to lead to the occurrence of infectious and inflammatory adverse events. A …

Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021

K Iwakiri, Y Fujiwara, N Manabe, E Ihara… - Journal of …, 2022 - Springer
In Japan, with the increasing prevalence of gastroesophageal reflux disease (GERD) and
growing public interest, the Japanese Society of Gastroenterology issued Evidence-based …

[HTML][HTML] Classification and guidelines of hemorrhoidal disease: present and future

M Rubbini, S Ascanelli - World journal of gastrointestinal surgery, 2019 - ncbi.nlm.nih.gov
Classification and guidelines of hemorrhoidal disease are based on the subdivision in
Grades of prolapse followed by any aspect related to both the treatment and its technique …